3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
4
Carcinoma, Renal Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Kidney Neoplasms
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia
2
Warts
1
Small Cell Lung Carcinoma
1
Recurrence
1
Papilloma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Lung Neoplasms
1
HIV Infections
1
Colorectal Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Mitomycin
9
Gemcitabine
5
apaziquone
3
Docetaxel
2
valrubicin
1
pembrolizumab
1
linrodostat
1
erdafitinib
1
enzalutamide
1
avelumab
1
VB4-845
1
Standard of Care
1
Nivolumab
1
Neoadjuvant Therapy
1
Hyaluronic Acid
1
DDMS
1
BCG Vaccine
1
Administration, Intravesical
1
ALT-801
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Non-Muscle Invasive Bladder Neoplasms
×
Interferon-alpha
×
Clear all
No trials found.